RPRX vs SQ
Royalty Pharma Plc (RPRX) versus SQ (SQ) — a side-by-side from cached financials, not a winner call.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
SQ (SQ) common stock.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
SQ does not have a complete income-statement cache yet.
RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the RPRX and SQ stock pages for the full models.
Not investment advice.